Fundraising Fox
Ron Hunt
InvestorManaging Director at New Leaf Venture Partners · Board director at CuraSen Therapeutics · Board director at Abcuro
New York, NY
Find your path to Ron
252 people in our graph can introduce you to Ron.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Alexander Rosen to introduce you to Ron
You →Alexander · together at Sprout Group (1998–2003) →Ron
Ask Jamie Chen to introduce you to Ron
You →Jamie · 2 people · together at Sprout Group →Ron
Ask Sam Okafor to introduce you to Ron
You →Sam · 9 people · together at New Leaf Venture Partners →Ron
Sign up to find every way you can get introduced to Ron
- Your email: the people you already email who know Ron
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Ron
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Ron Hunt is a Managing Director at New Leaf Venture Partners and one of the firm's founders, which he helped start in 2005. He focuses on early to late stage biopharmaceutical investments and has more than 25 years of experience investing in companies developing novel medicines. Before entering venture capital in 1998, he worked as a strategy and operations consultant to pharmaceutical and medical device clients, and held sales and marketing roles at Johnson & Johnson and SmithKline Beecham Pharmaceuticals. He holds an M.B.A. from The Wharton School and a B.S. from Cornell University.
Contact· self-published, not guessed
Invests in
Biotech
Board director at CuraSen Therapeutics
Intro paths
In turn, Ron can intro founders to CuraSen Therapeutics's investors below.
CuraSen Therapeutics's investors · 9
Co-founders at CuraSen Therapeutics
Board director at Abcuro
Intro paths
In turn, Ron can intro founders to Abcuro's investors below.
Abcuro's investors · 16
Co-founders at Abcuro
Experience
- New Leaf Venture PartnersManaging Directorcurrent2005 — present
- Sprout GroupPartner1998 — 2005
Skills & more
From Ron's professional profile.
Investments
Investor
Aspreva PharmaceuticalsCerexaDurata TherapeuticsHarpoon TherapeuticsIterum TherapeuticsNycomedPathology PartnersPhase ForwardRelypsaReViralSierra OncologyStromedix
Per the firm's website.
Colleagues at New Leaf Venture Partners
Frequently asked questions
- Who is Ron Hunt?
- Ron Hunt is a Managing Director at New Leaf Venture Partners and one of the firm's founders, which he helped start in 2005. He focuses on early to late stage biopharmaceutical investments and has more than 25 years of experience investing in companies developing novel medicines. Before entering venture capital in 1998, he worked as a strategy and operations consultant to pharmaceutical and medical device clients, and held sales and marketing roles at Johnson & Johnson and SmithKline Beecham Pharmaceuticals. He holds an M.B.A. from The Wharton School and a B.S. from Cornell University.
- Where does Ron Hunt work?
- Ron Hunt is Managing Director at New Leaf Venture Partners and Board director at CuraSen Therapeutics and Board director at Abcuro.
- What does Ron Hunt invest in?
- Ron Hunt invests in Biotech.
- What companies has Ron Hunt invested in?
- Investments tracked here include Aspreva Pharmaceuticals, Cerexa, Durata Therapeutics, Harpoon Therapeutics, Iterum Therapeutics, Nycomed, Pathology Partners, Phase Forward, Relypsa, ReViral, Sierra Oncology, Stromedix.
- Where did Ron Hunt go to school?
- Ron Hunt studied at The Wharton School (Master of Business Administration (MBA), Finance, General); Cornell University (Bachelor's Degree).
Same school
Also attended The Wharton School2,000
+ 1,994 more
Also attended Cornell University1,535
+ 1,529 more
